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discussions about risk among young patients with acute myocardial infarction (AMI) are not well studied.
OBJECTIVES This study compared cardiac risk factor prevalence, risk perceptions, and health care provider feedback on
heart disease and risk modiﬁcation between young women and men hospitalized with AMI.
METHODS We studied 3,501 AMI patients age 18 to 55 years enrolled in the VIRGO (Variation in Recovery: Role of
Gender on Outcomes of Young AMI Patients) study in U.S. and Spanish hospitals between August 2008 and January
2012, comparing the prevalence of 5 cardiac risk factors by sex. Modiﬁed Poisson regression was used to assess sex
differences in self-perceived heart disease risk and self-reported provider discussions of risk and modiﬁcation.
RESULTS Nearly all patients (98%) had$1 risk factor, and 64% had$3. Only 53% of patients considered themselves at
risk for heart disease, and even fewer reported being told they were at risk (46%) or that their health care provider had
discussed heart disease and risk modiﬁcation (49%). Women were less likely than men to be told they were at risk
(relative risk: 0.89; 95% conﬁdence interval: 0.84 to 0.96) or to have a provider discuss risk modiﬁcation (relative risk:
0.84; 95% conﬁdence interval: 0.79 to 0.89). There was no difference between women and men for self-perceived risk.
CONCLUSIONS Despite having signiﬁcant cardiac risk factors, only one-half of young AMI patients believed they were
at risk for heart disease before their event. Even fewer discussed their risks or risk modiﬁcation with their health care
providers; this issue was more pronounced among women. (J Am Coll Cardiol 2015;66:1949–57) © 2015 by the American
College of Cardiology Foundation.m the *Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut; yDepartment of
ergency Medicine, Yale School of Medicine, New Haven, Connecticut; zCenter for Outcomes Research and Evaluation, Yale-
w Haven Hospital, New Haven, Connecticut; xDepartment of Cardiology, Hospital General Universitario Gregorio Marañón,
drid, Spain; kSaint Luke’s Mid America Heart Institute and University of Missouri–Kansas City, Kansas City, Missouri; and the
ection of Cardiovascular Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine,
le School of Medicine and the Department of Health Policy and Management, Yale School of Public Health, New Haven,
nnecticut. The VIRGO study was supported by grant R01 HL081153-01A1K from the National Heart, Lung, and Blood Institute.
ABBR EV I A T I ON S
AND ACRONYMS
AMI = acute myocardial
infarction
CAD = coronary artery disease
CI = conﬁdence interval
RR = relative risk
STEMI = ST-segment elevation
myocardial infarction
Dr. Bueno
Servier, an
myopathy
scientiﬁc ad
authors ha
Manuscript
Leifheit-Limson et al. J A C C V O L . 6 6 , N O . 1 8 , 2 0 1 5
Risk Perceptions and Discussions Before AMI N O V E M B E R 3 , 2 0 1 5 : 1 9 4 9 – 5 7
1950H eart disease is the leading cause ofdeath and a major contributor todisability among women world-
wide. Although often considered a disease
of older age, more than 15,000 deaths each
year among women #55 years of age in the
United States can be attributed to heart
disease (1,2). Moreover, young women with
acute myocardial infarction (AMI) have
excess mortality compared with similarlyaged men (3–8). Sex differences in risk factors such
as diabetes mellitus, dyslipidemia, hypertension,
obesity, and cigarette smoking may contribute to
poorer outcomes for young women, but research is
limited in young patients with AMI (9,10). A recent
study found that multiple cardiac risk factors areSEE PAGE 1958highly prevalent in patients with AMI, and secondary
prevention efforts are less common among younger
patients (11). Prevention of heart disease and recur-
rent cardiac events requires that patients be aware
of their risk factors, be educated about their risk,
and perhaps most importantly, perceive themselves
to be at risk (12). Patients must also receive guidance
on ways to modify their risk. Although numerous
guidelines emphasize the importance of risk assess-
ment and patient education for improving the quality
of preventive care among women (13), both women
and their physicians underestimate the cardiovascu-
lar risk for women, particularly young women
(14–17). We sought to compare the prevalence of 5
potentially modiﬁable risk factors by sex in a cohort
of young patients hospitalized with AMI. We also
assessed sex differences in patient perceptions of
risk before the index AMI and discussions of heart
disease risk and risk modiﬁcation with health care
providers.
METHODS
STUDY POPULATION. Patients hospitalized with
AMI, age 18 to 55 years, were recruited between
August 2008 and January 2012 from 103 U.S. and 24
Spanish hospitals using a 2:1 female-to-male enroll-
ment design to participate in the VIRGO (Variation in
Recovery: Role of Gender on Outcomes of Young AMIhas received ﬁnancial support from AstraZeneca, Bayer, Daiichi-
d Ferrer. Dr. Spertus holds a copyright for the SAQ (Seattle Ang
Questionnaire), and the PAQ (Peripheral Artery Questionnaire). Dr
visory committee for United Health Care; and has received grants
ve reported that they have no relationships relevant to the conte
received February 25, 2015; revised manuscript received July 28Patients) study. The methods of VIRGO have been
described previously (18). In brief, eligible patients
had elevated cardiac biomarkers (troponin I or T or
creatine kinase-myocardial band), with at least 1
biomarker >99th percentile of the upper reference
limit at the recruiting center within 24 h of admission
(>97% of patients had qualifying troponin levels).
Additional evidence of acute myocardial ischemia
was required, including either symptoms of ischemia
or electrocardiogram changes indicative of new
ischemia (new ST-T changes, new or presumably new
left bundle branch block, or the development of
pathological Q waves). Patients must have presented
directly to the enrolling site or been transferred
within the ﬁrst 24 h of presentation. Patients who
were incarcerated, did not speak English or Spanish,
were unable to provide informed consent or be con-
tacted for follow-up, developed elevated cardiac
markers because of elective coronary revasculariza-
tion, or had an AMI as the result of physical trauma
were not eligible.
Of the 5,422 patients eligible for the VIRGO study,
3,501 were ultimately enrolled, including 2,985 in the
United States and 516 in Spain. Institutional review
board approval was obtained at each participating
institution, and patients provided informed consent
for their study participation.
DATA COLLECTION AND VARIABLES. Baseline pa-
tient data were collected by medical chart abstraction
and standardized in-person patient interviews
administered by trained personnel during the index
AMI admission. Sociodemographic factors included
age, sex, self-identiﬁed race (white, black, other),
Hispanic ethnicity, marital status, completed educa-
tion (< high school [1 to 11 years], high school
graduate [12 years], > high school [13þ years]), and
full- or part-time employment. Access-to-care factors
included lack of insurance, having a primary care
clinician, having a usual place for health care, and
visiting a heart specialist in the past year. Medical
history data included prior AMI, revascularization
procedure (percutaneous coronary intervention or
coronary artery bypass graft surgery), angina, con-
gestive heart failure, chronic kidney disease (esti-
mated glomerular ﬁltration rate #60 ml/min/1.73 m2),
chronic lung disease, and family history of coronarySankyo, Eli Lilly, Menarini Group, Novartis, Sanoﬁ,
ina Questionnaire), the KCCQ (Kansas City Cardio-
. Krumholz has served as chair of the cardiovascular
from Johnson and Johnson and Medtronic. All other
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1951artery disease (CAD). Clinical characteristics at
presentation were also noted, including ﬁnal AMI
diagnosis and ejection fraction <40%.
Information on 5 potentially modiﬁable risk factors
was ascertained from the medical record and the
patient interview. Diabetes mellitus was deﬁned as
glucose >200 mg/dl, hemoglobin A1c $6.5%, docu-
mented history of diabetes mellitus in the medical
record, self-reported history of diabetes mellitus, or
use of a glucose-lowering medication on arrival
(e.g., insulin or an oral antidiabetic agent) (19).
Dyslipidemia was deﬁned as total serum cholestero
$200 mg/dl, low-density lipoprotein cholesterol
$130 mg/dl, high-density lipoprotein cholesterol
<40 mg/dl, documented history of dyslipidemia in
the medical record, self-reported history of dyslipi-
demia, or use of a lipid-control medication on arrival
(e.g., statin, ﬁbrate, or niacin) (20). Hypertension was
deﬁned as a documented history of hypertension in
the medical record or self-reported hypertension.
Obesity was deﬁned as a body mass index $30 kg/m2
(21). Patients reporting a history of smoking within
the past 30 days were considered current smokers.
During the baseline interview, patients were asked
about their perceptions of risk and discussions of
heart disease risk and risk modiﬁcation with their
health care providers before the index AMI event.
Speciﬁc questions included the following. 1) “Prior to
your recent hospital stay, did you consider yourself at
risk for heart disease or a heart problem?” 2) “Prior to
your recent hospital stay, did any of your health care
providers ever tell you that you were at risk for
heart disease or a heart problem?” 3) “Did a doctor
ever talk to you about heart disease and talk about
things that you could do to take care of your heart?”
Possible responses for each question were “yes,”
“no,” or “don’t know.” Because <2% of patients re-
ported “don’t know” for these questions and there
were no differences by sex, we recoded this response
as missing.
STATISTICAL ANALYSIS. Sociodemographic character-
istics, health care access, medical history, clinical
characteristics at presentation, prevalence of indi-
vidual risk factors, perceived risk for heart disease,
and health care provider discussion of risk or risk
modiﬁcation before the index admission were
compared by sex and country by use of chi-square or
Fisher exact tests for categorical variables and
Wilcoxon rank sum tests for continuous variables.
The cumulative number of risk factors was deter-
mined for each patient (possible range from 0 to 5)
and also compared by sex and country as described
above.Modiﬁed Poisson regression models with robust
error variance (22) were used to calculate relative
risks (RRs) directly for the associations of sex with
perceived risk for heart disease and health care
provider discussion of risk or risk modiﬁcation.
Multivariable models adjusted for country, self-
reported race, education, lack of insurance, marital
status, presence of a primary care clinician, usual
place for care, family history of CAD, visiting a heart
specialist within the past year, and documented,
potentially modiﬁable cardiac risk factors (diabetes
mellitus, dyslipidemia, hypertension, obesity, and
smoking). The RRs were calculated for the overall
cohort and among subgroups deﬁned by documented
cardiac risk factors before the index event and family
history of CAD. Recognizing the potential importance
of a personal history of CAD (i.e., prior AMI event or
revascularization procedure) in patients’ perceptions
of risk and providers’ discussions of risk and risk
modiﬁcation, we repeated analyses in models strati-
ﬁed by personal history of CAD, as well as in models
stratiﬁed by whether the patient had visited a heart
specialist within the past year. We formally tested
interactions between these variables and sex. We
used a similar strategy to assess country as a modiﬁer,
repeating analyses separately for U.S. and Spanish
patients and testing the interaction between country
and sex.
Missing data were minimal for our study, with 10%
of patients missing data for any of the model vari-
ables (2.4% were missing data for >1 variable) and
no single variable missing for >5% of patients. All
statistical analyses were conducted with SAS version
9.3 (SAS Institute, Cary, North Carolina), with 2-tailed
tests for statistical signiﬁcance and a ¼ 0.05.
RESULTS
PATIENT CHARACTERISTICS. The VIRGO study
enrolled 2,349 women and 1,152 men hospitalized
with AMI. Patients ranged in age from 18 to 55 years,
had a median age of 48 years, and were predomi-
nantly white (78%). Women were more likely than
men to be nonwhite, unmarried, and unemployed
and to have less than a high school education
(Table 1). Although women were more likely to have a
primary care clinician and usual place for care,
women and men were equally as likely to have visited
a heart specialist in the past year. Approximately 19%
of patients had a previous AMI or revascularization
procedure, and comorbidities were common. Women
were more likely than men to have a history of
congestive heart failure, chronic kidney disease, and
chronic lung disease; men were more likely to have
TABLE 1 Patient Characteristics by Sex and Country
Overall United States Spain
Women
(n ¼ 2,349)
Men
(n ¼ 1,152) p Value
Women
(n ¼ 2,009)
Men
(n ¼ 976) p Value
Women
(n ¼ 340)
Men
(n ¼ 176) p Value
Sociodemographic characteristics
Age, yrs 48 (44–52) 48 (43–52) 0.266 48 (44–52) 48 (44–52) 0.286 47 (42–51) 47.5 (42–51) 0.774
Race <0.001 <0.001 0.663
White 75.9 83.5 72.9 81.6 93.8 94.3
Black 18.6 9.8 21.3 11.0 2.7 3.4
Other 5.5 6.7 5.8 7.5 3.5 2.3
Hispanic 7.6 8.0 0.660 7.7 8.4 0.477 7.1 5.7 0.555
Married/cohabitating 55.3 64.2 <0.001 52.6 62.3 <0.001 71.2 74.9 0.386
Completed education 0.010 0.004 0.457
< High school 21.8 17.9 15.9 11.9 59.2 54.4
High school graduate 25.0 28.4 27.3 31.5 10.4 9.5
> High school 53.2 53.7 56.8 56.6 30.4 36.1
Working full- or part-time 56.4 73.4 <0.001 56.3 72.0 <0.001 56.9 81.1 <0.001
Health care access
No health insurance 18.7 21.4 0.063 21.6 24.9 0.042 1.5 1.2 0.774
Currently has a primary care clinician 74.5 66.1 <0.001 74.9 66.7 <0.001 71.7 62.6 0.036
Usual place for care: none/ED 7.6 12.8 <0.001 8.2 13.4 <0.001 3.7 9.4 0.009
Previously seen by heart specialist 32.7 32.2 0.776 34.7 34.3 0.827 20.8 20.5 0.924
Medical history
Prior MI 14.8 16.9 0.105 16.3 18.9 0.086 5.9 6.3 0.868
Prior PCI or CABG 14.6 18.0 0.010 16.4 20.4 0.008 3.8 4.5 0.694
Angina 27.5 26.1 0.373 27.4 26.2 0.490 28.3 25.6 0.507
Congestive heart failure 5.0 2.1 <0.001 5.8 2.5 <0.001 0.3 0.0 1.000
Family history of CAD 76.0 73.5 0.120 77.6 76.7 0.559 66.4 56.5 0.031
Chronic kidney disease 11.6 7.8 0.001 12.7 8.6 0.001 5.0 3.4 0.406
COPD 12.6 5.5 <0.001 14.2 6.4 <0.001 3.2 0.6 0.067
Clinical characteristics at presentation
Final diagnosis: STEMI 47.9 59.5 <0.001 45.9 57.7 <0.001 60.0 69.3 0.038
Ejection fraction <40% 10.6 11.2 0.593 10.9 11.6 0.589 9.0 9.3 0.906
Values are median (interquartile range) or %.
CABG ¼ coronary artery bypass graft; CAD ¼ coronary artery disease; COPD ¼ chronic obstructive pulmonary disease; ED ¼ emergency department; MI ¼ myocardial infarction; PCI ¼
percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
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1952previously undergone revascularization and to pre-
sent with an ST-segment elevation myocardial
infarction (STEMI). Sex differences in employment,
having a primary care clinician or usual place for care,
and STEMI diagnosis persisted across countries. Dif-
ferences in race, marital status, education, insurance,
revascularization, and comorbidities were observed
only for U.S. patients. Among patients in Spain,
women were more likely than men to report a family
history of CAD. Patients within the United States
versus those in Spain were more racially diverse, less
likely to be married or insured, and more likely to
have comorbid conditions and a history of AMI or
revascularization. STEMI was more common in
Spanish than U.S. patients.
RISK FACTORS. Nearly all women (97%) and men
(99%) had at least 1 of the 5 potentially modiﬁable riskfactors assessed in this study, and 65% of women and
63% of men had 3 or more. The most common risk
factor was dyslipidemia (86%), followed by hyper-
tension (63%), current smoking (60%), obesity (49%),
and diabetes mellitus (35%). With the exception of
smoking, all risk factors were more prevalent among
patients in the United States than among those in
Spain (Table 2). Across countries, women were more
likely than men to have diabetes mellitus (relation-
ship only statistically signiﬁcant among U.S. pa-
tients), but they were less likely to have dyslipidemia.
Women in the United States were also more likely to
be obese than their male counterparts. Hypertension
and smoking were prevalent but did not differ
markedly by sex in either country.
RISK PERCEPTIONS AND DISCUSSIONS WITH
PROVIDERS. Approximately one-half of women and
TABLE 2 Modiﬁable Risk Factors by Sex and Country
Overall United States Spain
Women
(n ¼ 2,349)
Men
(n ¼ 1,152) p Value
Women
n ¼ 2,009
Men
(n ¼ 976) p Value
Women
(n ¼ 340)
Men
(n ¼ 176) p Value
Diabetes 38.8 26.7 <0.001 39.9 26.7 <0.001 32.4 26.7 0.186
Dyslipidemia 82.6 92.1 <0.001 83.7 92.9 <0.001 76.5 87.5 0.003
Hypertension 63.8 62.3 0.391 67.1 64.7 0.176 44.1 49.4 0.251
Obesity 51.0 44.6 <0.001 55.3 47.7 <0.001 25.2 27.2 0.635
Smoking 59.7 59.3 0.811 57.7 56.6 0.578 71.8 74.3 0.543
Total number of risk factors <0.001 <0.001 0.286
0 3.0 1.2 3.1 1.1 2.6 1.7
1 11.2 10.2 10.2 10.1 17.1 10.2
2 20.5 26.1 18.6 24.5 32.1 35.2
3 28.4 33.9 28.2 34.2 29.7 31.8
4 26.1 22.3 28.2 23.3 13.2 17.0
5 10.9 6.3 11.8 6.8 5.3 4.0
Values are %.
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1953men in the United States reported that before their
index AMI event, they considered themselves at risk
for heart disease (56%), were told by a health care
professional that they were at risk (50%), or had a
health care provider talk to them about heart disease
and ways to modify their risk (53%). The proportion of
Spanish patients was even lower, with only 36%
reporting prior perceived risk for heart disease, 26%
reporting a health care professional had told them
they were at risk, and 22% reporting that a health care
provider had talked to them about heart disease
and ways to modify risk. In the United States andFIGURE 1 Perceptions and Discussions of Risk by Sex and Country
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were told by a health care professional that they were at risk, or had a h
p Values for comparisons by sex within the overall, U.S., and Spanish coSpain, a smaller proportion of women than men
reported prior self-perceived risk or discussions
about risk or risk modiﬁcation with their health care
providers, although the relationships were only sta-
tistically signiﬁcant for discussions of risk or risk
modiﬁcation among U.S. patients (Figure 1).
In risk-adjusted models that included both U.S.
and Spanish patients, women were 11% less likely
than men to report being told they were at risk for
heart disease (RR: 0.89; 95% conﬁdence interval [CI]:
0.84 to 0.96) and 16% less likely than men to report
having a health care provider discuss heart diseaseU.S. Spain Overall U.S. Spain
ovider Told At–Risk Provider Discussed Heart
Disease and Risk Modification
48.7
52.9
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myocardial infarction event, they considered themselves at risk for heart disease,
ealth care provider talk to them about heart disease and ways to modify their risk.
horts were calculated with chi-square tests.
CENTRAL ILLUSTRATION Risk Perceptions and Discussions Before AMI: Risk-Adjusted Associations of Sex (Women vs. Men) With
Perceptions and Discussions of Risk
Leifheit-Limson, E.C. et al. J Am Coll Cardiol. 2015; 66(18):1949–57.
Adjusted relative risks and 95% conﬁdence intervals for women versus men were calculated for the overall cohort, among subgroups of patients deﬁned by documented
modiﬁable risk factors (diabetes, dyslipidemia, hypertension, obesity, current smoking) and family history of coronary artery disease, among those with and without a personal
history of coronary artery disease (i.e., prior acutemyocardial infarction or revascularization procedure), and among those who did and did not visit a heart specialist in the past
year.$3RFs¼patienthas at least3 of the5potentiallymodiﬁable risk factors;CAD¼ coronary arterydisease;DM¼diabetes historydocumented in themedical chart orglucose-
loweringmedicationonarrival; DYSLIP¼ dyslipidemiahistory documented in themedical record or lipid-controlmedication onarrival; FAMHX¼ family history of coronary artery
disease; HTN ¼ hypertension history documented in the medical chart; OBESE ¼ body mass index$30 kg/m2; SMOKE ¼ current smoking within the past 30 days.
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1955and ways to modify risk (RR: 0.84; 95% CI: 0.79
to 0.89) before their index AMI event (Central
Illustration). The association of sex with prior
perceived risk of heart disease was not statistically
signiﬁcant (RR: 0.94; 95% CI: 0.89 to 1.00). These
relationships remained fairly consistent across pa-
tient subgroups deﬁned by 5 documented modiﬁable
risk factors (diabetes mellitus, dyslipidemia, hyper-
tension, obesity, and current smoking) and by family
history of CAD. A personal history of CAD moderated
the relationships between sex and provider discus-
sions of risk (p for interaction ¼ 0.067) and risk
modiﬁcation (p for interaction ¼ 0.002). Women
without a history of CAD were 15% less likely than
men without a CAD history to report being told they
were at risk (RR: 0.85; 95% CI: 0.77 to 0.95), but there
was no signiﬁcant sex difference among patients with
a documented history of CAD (RR: 0.98; 95% CI: 0.92
to 1.03). Regarding provider discussion of heart dis-
ease and ways to modify risk, women without a his-
tory of CAD were 21% less likely than men to report
such discussions (RR: 0.79; 95% CI: 0.72 to 0.87).
Among those with a documented history of CAD,
women were 6% less likely than men to report dis-
cussions (RR: 0.94; 95% CI: 0.89 to 0.99). There was
an interaction between sex and being seen by a heart
specialist in the past year for each of the 3 risk
perception/discussion variables (p for interaction was
0.016 for perceived risk of heart disease, 0.072 for
provider discussion of risk, and 0.002 for provider
discussion of heart disease and risk modiﬁcation).
Among those who had not seen a heart specialist in
the past year, women were signiﬁcantly less likely
than men to perceive themselves to be at risk (RR:
0.88; 95% CI: 0.79 to 0.97), report being told they
were at risk (RR: 0.83; 95% CI: 0.73 to 0.93), and
report having a provider discuss heart disease and
risk modiﬁcation (RR: 0.76; 95% CI: 0.68 to 0.85).
Among those who had seen a heart specialist, sex
was signiﬁcantly associated with discussion of heart
disease and risk modiﬁcation (RR: 0.92; 95% CI: 0.87
to 0.97 for women vs. men). Interactions between
sex and country were nonsigniﬁcant in all models
(all p > 0.2); however, the relationships appeared
somewhat stronger among Spanish versus U.S.
patients (Online Table 1).
DISCUSSION
In this multicenter study of young women and men
hospitalized with AMI in the United States and
Spain, the burden of traditional cardiac risk factors
was high, with nearly all patients presenting with at
least 1 modiﬁable risk factor and nearly two-thirdspresenting with 3 or more. Despite women having a
similar or possibly greater risk factor burden than
men, they were 11% less likely to report that their
health care providers had told them they were at risk
for heart disease before the index AMI event and 16%
less likely to report having had a provider talk with
them about heart disease and ways to modify risk.
This inequity largely persisted across cardiac risk
factors, was more pronounced among patients
without a history of CAD and among those who had
not visited a heart specialist in the year before the
index AMI, and was observed for patients in both the
United States and Spain.
Only 53% of the young patients in our study re-
ported that they believed they were at risk for heart
disease before their AMI hospitalizations. Even more
striking were the lower reported rates of provider
feedback on and discussion of heart disease risk
(46%) and risk factor management (49%) among
these patients with documented risk factors, partic-
ularly young women. Whether these ﬁndings reﬂect
actual practice patterns, a lack of effective commu-
nication about heart disease risk and risk modiﬁca-
tion, or potentially a perceived reduced risk because
of young age (23) is unclear. Regardless, the ﬁndings
underscore the importance of improved risk identiﬁ-
cation, clinical management, and patient education
for adults age #55 years, with an emphasis on
women.
Although heart disease awareness among women
has increased in recent decades, it remains sub-
optimal (24). The 2012 American Heart Association
National Women’s Survey revealed that only 56% of
women respondents cited heart disease as the leading
cause of death in women, and only 48% of women
considered themselves very well or well informed
about heart disease in women. Although awareness
has improved from a 1997 survey, no further im-
provements have occurred since 2009. In 2012, only
21% of respondents reported that their doctors ever
discussed their risk for heart disease, and this pro-
portion varied by age, with only 6% of women age
25 to 34 years reporting such a discussion, 16% of
those age 35 to 44 years, 23% of those age 45 to 64
years, and 33% of those age 65 years or older.
Although approximately 45% of the young women in
our study reported that their health care providers
discussed heart disease risk and modiﬁcation, this
is not reassuring given our cohort is composed of
patients with premature heart disease who have a
high prevalence of traditional cardiac risk factors and
a family history of CAD. Building on the ﬁndings of
these previous studies, we found that young women
were signiﬁcantly less likely than young men to
PERSPECTIVES
COMPETENCY IN SYSTEMS-BASED PRACTICE:
Young men and women with cardiovascular risk
factors often do not receive counseling on their risk of
cardiac events or ways to modify risk. Physicians
should take greater advantage of opportunities to
improve risk awareness.
TRANSLATIONAL OUTLOOK: More effort is
needed to identify effective ways to alert young
people to cardiovascular risk factors and their
modiﬁcation to reduce morbidity and mortality.
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1956report discussions of heart disease risk and risk
modiﬁcation before their AMI hospitalizations. This
sex difference persisted after taking into account
sociodemographic characteristics, health care access,
medical history, and the presence of traditional risk
factors for heart disease. Moreover, the relationship
was evident across multiple subgroups of patients
with documented risk factors, including those with
diabetes mellitus, a factor known to confer a partic-
ularly high risk for heart disease and fatal cardiac
events (13,25,26), and those presenting with at least
3 of 5 potentially modiﬁable risk factors.
Diabetes mellitus, dyslipidemia, hypertension,
obesity, and cigarette smoking are well-established
risk factors for heart disease development and prog-
nosis. Our ﬁndings are consistent with those of pre-
vious studies reporting a high percentage of patients
hospitalized with AMI presenting with at least 1 of
these traditional, and potentially modiﬁable, risk
factors for heart disease (11,27–30). Few studies,
however, provide sufﬁcient data to assess sex differ-
ences in these risk factors among a young population
of patients with AMI (11,29,31–34). Similar to prior
studies that included younger patients with AMI in
the United States (11,31,34), Sweden (33), and Canada
(32), we found that young women in both the United
States and Spain were more likely to present with
diabetes mellitus than young men. As in prior U.S.
studies (11,31,34), young women in the United States
were also more likely to be obese, and young men in
both the United States and Spain were more likely to
have dyslipidemia. In contrast to prior studies, we
did not observe a sex difference in hypertension
(11,31–34) or current smoking status (31,33), which
may in part reﬂect differences in risk factor deﬁni-
tions. Regardless, rates of these risk factors were
high, with 60% of our cohort being current smokers
and 63% being hypertensive. Collectively, these re-
sults highlight the unfavorable risk factor proﬁles of
young patients with AMI. Our study extends these
ﬁndings by including patients from both the United
States and Spain and by assessing whether these
traditional and potentially modiﬁable cardiac risk
factors impact sex differences in patients’ per-
ceptions of risk and recollection of heart disease
counseling by their health care providers.
STUDY LIMITATIONS. There are several issues to
consider when interpreting our results. Only patients
hospitalized with AMI who survived and provided
consent were enrolled in the VIRGO study. Risk factor
information was obtained via medical chart review
and may be limited by the availability of documented
information on the presence and clinical managementof risk factors. Information was supplemented with
direct patient interview about risk factors, but it may
be subject to recall bias and awareness of risk factor
status. We relied on self-report of risk discussions
with providers, and these may not reﬂect actual
practice patterns; although it is possible more dis-
cussions of risk and risk modiﬁcation may have
occurred, the lack of patient recall suggests that
they were not effective. Finally, our results may
not be generalizable to patients with AMI seen at
nonparticipating hospitals. However, VIRGO is one of
the largest cohorts of women and men age #55 years
hospitalized with AMI, and the composition of our
cohort and prevalence of comorbidities and risk fac-
tors are consistent with other studies of younger pa-
tients with AMI (34).
CONCLUSIONS
Although both young men and women had a high
risk factor burden, young women were less likely
than men to be informed about heart disease. Our
results highlight opportunities to improve patient
knowledge and perceptions of heart disease risk.
Optimization of the delivery of health information
to younger patients, particularly those with multiple
cardiac risk factors, represents an important prac-
tice target for health care providers and may
potentially reduce the morbidity and mortality
associated with heart disease and acute cardiac
events.
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